Research methods
HLA approximation in glioma
A pre-specified methods study examining HLA approximation and predicted neoantigen burden.
Repository reports Stages 1–2 complete and binding prediction pending; not clinical validation.
Complete reading collection
Documents & supporting records
Full documents with local navigation. Supporting code and records are presented for inspection; files are not executed by reading them.
- HLA approximation and predicted neoantigen burden in low-mutation gliomaREADME.md
- Analysis plan — HLA approximation and neoantigen burden in low-mutation gliomaANALYSIS_PLAN.md
- Stage 1 results — 26 October 2026STAGE1-2_RESULTS.md
- DisclaimerDISCLAIMER.md
- Data acquisitiondocs/data_acquisition.md
- LICENSELICENSE
- results/cohort.csvresults/cohort.csv
- results/pipelineattrition.csvresults/pipeline_attrition.csv
- Pre-specified in the analysis plan. Same panel as the withdrawn analysis, sosrc/stage3.py